ArticleBriefings in bioinformatics2025
CKG-TPI: integrating collaborative knowledge graph with sequence interactions for TCR-peptide binding specificity.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Accurately identifying interactions between T-cell receptors (TCRs) and peptides is a fundamental challenge in immunology, with significant implications for vaccine design and immunotherapy. While computational methods offer efficient alternatives to labor-intensive experimental screening, achieving robust and accurate TCR-peptide binding prediction remains a challenging task. To address this, we propose collaborative knowledge graph (CKG-TPI), a novel prediction framework based on graph neural networks that integrates both interaction patterns between TCR and peptide sequences and their higher-order biological context through a constructed collaborative knowledge graph. Experimental results on multiple publicly available independent datasets demonstrate that CKG-TPI consistently outperforms state-of-the-art models. Specifically, it achieves a 9.89% improvement in area under the ROC curve compared to the strongest baseline model UnifyImmun, and a 23.93% increase in area under the precision-recall curve over the leading baseline method. Moreover, attention weight visualization and peptide-specific TCR screening validate the model's effectiveness, underscoring its potential as a powerful tool for immunological research and therapeutic discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.